, end of June 30, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 increase (decrease) Q1/2020 Q1/2019 Revenue from sales 85.68 121.53 (35.85) (29.50%) 100.00
Public Company Limited (“the Company”) would like to submit the Management Discussion and Analysis for the second quarter ended June 30, 2020 as follows: Revenue from Sales For the first 6 months of 2020
months, end of March 31, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 Increase (decrease) Q1/2020 Q1/2019 Revenue from sales 45.46 67.47 (22.01 ) (32.62
: million Baht) For 9 months, end of September 30, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q3/2020 Q3/2019 increase(decrease) Q3/2020 Q3/2019 Revenue from sales 117.39
Unit: Million Baht million baht % million baht % million baht % Revenue from sales of real estate 238.90 98.68 238.90 98.39 169.60 97.98 69.30 40.86 Other income 3.19 1.32 3.92 1.61 3.49 2.02 0.43 12.32
follows: Total revenue was THB 4,438.11 million, a decrease of THB 108.7 million or 2.39%. The main businesses of the Company and its subsidiaries were as follows: Operating results : 9 months 2019 2018
earnings im- pact from the seasonal maintenances. Figure 1: IVL Quarterly Core EBITDA (LTM) The steady improvement seen in core earnings follows on from IVL’s strategy of prudent invest- ments in the higher
THB million % THB million % Sales THB million % Sales THB million % Revenue from Sales 4,346.60 100.00 3,979.59 100.00 367.01 9.22 8,312.61 100.00 7,712.69 100.00 599.92 7.78 Gross Profit 602.83 13.87
us to continue to sell at all times and create a steady stream of operating cash flows. 1Q 2020 Summary Financials Table 1: Core Financials of Consolidated Business $million (except where stated
Company and its subsidiary for the fiscal year ended on 31 December 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical